Pr Charles COUTANT

Habilitation à Diriger des Recherches (HDR) - Université Paris 6 - Pierre et Marie Curie

Diplôme d'État de docteur en sciences - Université Paris 6 - Pierre et Marie Curie

Doctorat d’État en médecine - Université Paris 5 - Paris-Descartes

D.I.U. Échographie et techniques ultrasonores - Echographie appliquée en gynécologie - Université Paris 6 - Pierre et Marie Curie

D.I.U. Coloscopie et pathologie cervico-vaginale - Université Paris 6 - Pierre et Marie Curie

Master Sciences biologiques et médicales - Université Paris 11 - Paris-Sud

Executive Master "Gestion et politique de santé" - Institut d'Etudes Politiques - Science Po Paris

Professeur des universités-praticien hospitalier - Centre Georges-François Leclerc (CGFL) - Dijon - Département Chirurgie Oncologique

Chef de service - Centre Georges-François Leclerc (CGFL) - Dijon - Département de Chirurgie Oncologique

Praticien hospitalier - Hôpital Tenon - Paris - Service de Gynécologie Oncologique

Fellow - MD Anderson Cancer Center - Houston, Texas USA - Breast medical oncology

Chef de clinique - Hôpital Tenon - Paris - Service de Gynécologie Oncologique et Obstétrique

Interne - Assistance Publique - Hôpitaux de Paris (AP-HP) - AP-HP

Adhérent - American Society of Clinical Oncology (ASCO)

Expert - Collège National des Gynécologues et Obstétriciens Français (CNGOF)

Adhérent - European Society for Medical Oncology (ESMO)

Expert - Société Francophone de Chirurgie Oncologique (SFCO)

Administrateur - Société Française de Sénologie et de Pathologie Mammaire (SFSPM)

Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort. Bull Cancer 2022; 109(3): 268-279. - Article

Para-aortic lymph node staging in grade IB2 and above cervical cancers: Comparison of 18FDG PET-CT with para-aortic lymphadenectomy, using data from the Côte d'Or gynaecological cancer registry from 2003 to 2016.Gynecol Obstet Fertil Senol 2021 ; 49(9): 6 - Article

Strategies in case of metastatic sentinel lymph node in breast cancer. Bull Cancer 2020; 107(6): 672-685. - Article

Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study group. Eur J Surg Oncol 20 - Article

Comparing prediction performances of 18F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after neoadjuvant chemotherapy for HER2-positive breast cancers. Gynecol Obstet Fertil Senol 2020; 48(9): 679-686. - Article

Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and the Tenon score. Results of the NOTEGS - Article

Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: Results of a retrospective multicenter study. Gynecol Oncol 2014; 133(3): 506-11. - Article

Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers. Clin Cancer Res 2011 ; 17(8): 2591-601. - Article

Prospective multicenter comparison of models to predict four or more involved axillary lymph nodes in patients with breast cancer with one to three metastatic sentinel nodes. J Clin Oncol 2009; 27(34): 5707-12. - Article

Comparison of models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multi-center study. J Clin Oncol 2009; 27(17): 2800-8. - Article

Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer. Ann Oncol 2007; 18: 1513-7. - Article